CBNPC de stades précoces (I. II. IIIA)

Randomized trials demonstrated a beneficial effect in case of early NSCLC stages. The improvement is certain for stage II concerning both the quality of resection and the survival. In case of NSCLC stage I, neo-adjuvant chemotherapy is still a matter of debate.